University of Bedfordshire
Bedford, Bedfordshire, MK41 9EA, United Kingdom
NCT Number: NCT03898206
The purpose of this study is to examine whether breaking up prolonged sitting with short regular bouts of walking can reduce blood sugar and cholesterol levels after eating, which are risk markers for Type 2 diabetes and heart disease. This study will compare these responses in normal-weight versus overweight/obese South Asian adults.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Bedford, Bedfordshire, MK41 9EA, United Kingdom
Participants will attend a preliminary testing session where height, weight, body fat and waist circumference will be measured. They will be familiarised with a motorised treadmill that will be used during the experimental visit below and will take part in an exercise test to determine a light-intensity walking speed for the experimental visit.
Participants will then attend two experimental visits in a random order:
During each visit, blood pressure will be taken 11 times and blood samples will be taken 10 times. Participants will be given a breakfast and lunch meal to consume.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
See Breaking up sitting with walking breaks arm description
See Prolonged sitting arm description
Time frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for glucose
Time frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for triglycerides
Time frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for insulin
Time frame: Measured over the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for the Metabolic Load Index (MLI).
The MLI will be calculated using the following equation:
MLI (mmol.L-1) = blood glucose (mmol.L-1) + TAG (mmol.L-1). Lower values of MLI are considered better for cardiometabolic health!
Time frame: Measured for the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for resting energy expenditure
Time frame: Measured for the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for resting fat oxidation
Time frame: Measured for the 5 hour condition period
Incremental area under the curve for each 5 h condition will be calculated for resting carbohydrate oxidation
Time frame: Measured over the 5 hour condition period
Mean Arterial Pressure (MAP) over the 5 h conditions.
The following formula will be used to calculate MAP, where P is blood pressure (systolic or diastolic):
MAP = PDiastolic + 1/3 (PSystolic - PDiastolic).
Time frame: Measured over the 5 hour condition period
Mean heart rate over the 5 h conditions
University of Bedfordshire
Other
Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in Normal Weight Versus Overweight and Obese South Asian Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04645875
Behavior, Cardiovascular Diseases
Bedford, United Kingdom
View Trial DetailsNCT03443635
Behavior, Behavioral Symptoms
New Orleans, Louisiana, United States
View Trial DetailsNCT03528031
Behavior, Behavior, Animal
Loma Linda, California, United States
View Trial DetailsNCT03543644
Body Weight, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial Details